Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
about
Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injuryVaccine prevention of cancer: can endogenous antigens be targeted?Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesisDepletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responsesThe novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.Immunological milieu in the peritoneal cavity at laparotomy for gastric cancerNovel therapy for locally advanced triple-negative breast cancer.Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencingAdvances in dendritic-cell-based therapeutic vaccines for cervical cancer.The effects of immunosuppression on regulatory CD4(+)CD25(+) T cells: impact on immunosuppression selection in transplantation.Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablationCellular immunotherapy for ovarian cancer.Combination therapy using IL-2 and anti-CD25 results in augmented natural killer cell-mediated antitumor responses.High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction.DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.Trends in therapeutic monoclonal antibodies of cancer.Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells.Cancer immunotherapy using tumor cryoablation.Induction of antitumor immunity using dendritic cells electroporated with Polo-like kinase 1 (Plk1) mRNA in murine tumor models.Effective immunotherapy of weakly immunogenic solid tumours using a combined immunogene therapy and regulatory T-cell inactivation.Adoptive transfer of cytotoxic T-cells for treatment of residual disease after irradiation.3-Methylcholanthrene-induced transforming growth factor-beta-producing carcinomas, but not sarcomas, are refractory to regulatory T cell-depletion therapy.Inhibitory effect of live-attenuated Listeria monocytogenes-based vaccines expressing MIA gene on malignant melanoma.
P2860
Q30435312-4ADA6571-2542-4652-A2E6-588C7DFBEB30Q33783609-58C70418-BD6E-4220-999F-236BD674414DQ33800533-37E59362-32BC-47D2-98F1-8AF7C764B9BDQ33930139-82DC2597-8F67-466D-8BB9-FF47A6065C62Q34451999-0D440020-16E5-40C3-8E67-2B8C1BA22467Q35207756-F8DDAEDD-509C-4886-9CFD-768911E67FF7Q35872049-AAE1D15E-239F-4BEB-A027-F947F34655B0Q36094096-1C941A0B-E255-404E-B971-E83B7E3B44EBQ36107953-D6EEF1F1-4CA5-4240-92B9-2C4858828BAEQ36974722-B7CC77AB-C46B-49F9-AF35-60851A47A917Q37176386-BA3CF8BD-3C10-4155-A7AE-CCD7C6F416A1Q37268005-6747C126-3ADF-4B30-832F-7F1F72CA4A57Q37283379-38812DFC-4445-4724-8458-5A73BBA12340Q37327064-998ABB9F-6964-4419-AFD8-256A5412D70FQ37355703-2E50A6A8-4CC2-4D90-B161-215D8D8BCF21Q37395354-09459E01-831B-47EE-AAA1-B2C9944EF07EQ37412327-E11DC548-E843-4F42-BA2C-D07899368546Q37689796-CF58B67B-5C91-4C44-8EF1-D5DA0863C28DQ37829504-85BFB803-691F-4138-8968-194C39A291BAQ38096466-D8229818-43C1-4792-A0A4-A6D74E9D0100Q38171573-B24CB412-4673-43C4-9686-FA9740474885Q39547514-D6DCBEF8-2BF4-4686-A1B3-A606B7C70F70Q39734928-91F6C90E-0864-4069-B92D-139F0F9551E7Q40081629-790E7CF6-B944-4003-A314-61C54184391BQ43163965-D7F8049E-D215-4C1E-A89A-8BA59F351B85Q54296972-2CF996FB-8915-4946-BC09-00AA1C7C98F5
P2860
Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Depletion of CD4+CD25+ regulat ...... model of colon adenocarcinoma.
@en
type
label
Depletion of CD4+CD25+ regulat ...... model of colon adenocarcinoma.
@en
prefLabel
Depletion of CD4+CD25+ regulat ...... model of colon adenocarcinoma.
@en
P2093
P2860
P1433
P1476
Depletion of CD4+CD25+ regulat ...... model of colon adenocarcinoma.
@en
P2093
Guan-Feng Ouyang
Hiroyuki Tomita
Hisashi Imai
Jiro Nakagawa
Kenichi Nonaka
Masanao Saio
Shinji Osada
Tatsuhiko Suwa
Tsuyoshi Takami
Yasuyuki Sugiyama
P2860
P304
P356
10.1111/J.1349-7006.2006.00385.X
P577
2007-03-01T00:00:00Z